Costel Chirila

570 total citations
35 papers, 423 citations indexed

About

Costel Chirila is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Costel Chirila has authored 35 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Physiology. Recurrent topics in Costel Chirila's work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Costel Chirila is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Costel Chirila collaborates with scholars based in United States, Germany and France. Costel Chirila's co-authors include James A. Kaye, Josephine Mauskopf, Lee Bowman, Kristina S. Boye, Ellen J. Hahn, Julie Birt, Mary Kay Rayens, M. Fernandez, Dirk Eßer and Petra Moroni-Zentgraf and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Costel Chirila

32 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Costel Chirila United States 13 138 117 82 74 42 35 423
S.M. Babineaux United States 6 109 0.8× 132 1.1× 85 1.0× 40 0.5× 11 0.3× 11 397
Aaron Galaznik United States 13 28 0.2× 74 0.6× 134 1.6× 32 0.4× 19 0.5× 43 460
Anna Moseley United States 11 66 0.5× 26 0.2× 286 3.5× 106 1.4× 72 1.7× 34 606
Simran Padam United States 7 133 1.0× 79 0.7× 266 3.2× 161 2.2× 59 1.4× 16 572
Jeannette M. Day United States 8 87 0.6× 38 0.3× 269 3.3× 17 0.2× 43 1.0× 12 393
Anne Prenzler Germany 14 111 0.8× 29 0.2× 175 2.1× 123 1.7× 83 2.0× 30 585
William T. Leslie United States 5 77 0.6× 138 1.2× 232 2.8× 56 0.8× 44 1.0× 15 484
Winifred K. Rossi United States 7 28 0.2× 88 0.8× 114 1.4× 37 0.5× 20 0.5× 8 401
Andrew R. Wong United States 5 56 0.4× 67 0.6× 146 1.8× 157 2.1× 71 1.7× 9 436
Saira Khan United States 11 102 0.7× 32 0.3× 100 1.2× 21 0.3× 39 0.9× 43 325

Countries citing papers authored by Costel Chirila

Since Specialization
Citations

This map shows the geographic impact of Costel Chirila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Costel Chirila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Costel Chirila more than expected).

Fields of papers citing papers by Costel Chirila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Costel Chirila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Costel Chirila. The network helps show where Costel Chirila may publish in the future.

Co-authorship network of co-authors of Costel Chirila

This figure shows the co-authorship network connecting the top 25 collaborators of Costel Chirila. A scholar is included among the top collaborators of Costel Chirila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Costel Chirila. Costel Chirila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Law, Ernest H., et al.. (2025). Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial. Journal of Dermatological Treatment. 36(1). 2460577–2460577. 1 indexed citations
4.
Kummar, Shivaani, Lin Shen, Cornelis M. van Tilburg, et al.. (2022). Updated health-related quality of life of patients with TRK-fusion cancer treated with larotrectinib in clinical trials.. Journal of Clinical Oncology. 40(16_suppl). 6563–6563. 1 indexed citations
5.
Walters, Mark C., John F. Tisdale, Markus Y. Mapara, et al.. (2021). Sustained Improvements in Patient-Reported Quality of Life up to 24 Months Post-Treatment with LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy. Blood. 138(Supplement 1). 7–7. 3 indexed citations
6.
Kummar, Shivaani, Cornelis M. van Tilburg, Catherine M. Albert, et al.. (2020). Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population.. Journal of Clinical Oncology. 38(15_suppl). 3614–3614. 6 indexed citations
7.
Magrey, Marina, Esther Yi, Daniel Wolin, et al.. (2020). Understanding Barriers in the Pathway to Diagnosis of Ankylosing Spondylitis: Results From a US Survey of 1690 Physicians From 10 Specialties. ACR Open Rheumatology. 2(10). 616–626. 16 indexed citations
8.
Magrey, Marina, Daniel Wolin, Margaret Mordin, et al.. (2019). Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab. Clinical Drug Investigation. 39(12). 1205–1212. 7 indexed citations
10.
Andreas, Stefan, C. Chouaïd, Sarah Danson, et al.. (2018). Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer. 124. 298–309. 37 indexed citations
11.
Chirila, Costel, et al.. (2017). Health care resource use analysis of paliperidone palmitate 3 month injection from two phase 3 clinical trials. Current Medical Research and Opinion. 33(6). 1083–1090. 5 indexed citations
12.
Chirila, Costel, Debanjali Mitra, Ann Colosia, et al.. (2016). Efficacy of Palbociclib Combinations Versus Endocrine Therapies in Advanced/ Metastatic Breast Cancer: Network Meta-Analysis. Value in Health. 19(7). A710–A710. 3 indexed citations
13.
Bateman, Eric D., Dirk Eßer, Costel Chirila, et al.. (2015). Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis. Journal of Allergy and Clinical Immunology. 136(4). 914–922. 49 indexed citations
15.
Mauskopf, Josephine, Costel Chirila, James E. Graham, et al.. (2013). Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. American Journal of Health-System Pharmacy. 70(17). 1518–1527. 13 indexed citations
16.
Chirila, Costel, Stephanie Earnshaw, & Libby Black. (2012). Economic Analysis: Randomized, Placebo-Controlled Clinical Trial of Dutasteride in Men at High Risk for Prostate Cancer. Journal of Cancer Science & Therapy. 1(S3).
17.
Mauskopf, Josephine, et al.. (2011). PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEM. Value in Health. 14(3). A22–A23. 1 indexed citations
18.
Chirila, Costel, Dawn Odom, Giovanna Devercelli, et al.. (2011). Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer. International Journal of Colorectal Disease. 27(5). 623–634. 25 indexed citations
19.
Brabie, Gheorghe, et al.. (2004). Determination off the weld metal properties and behaviour in the case off tailor-welded blanks using the parallel tensile test and image-analysis method. Archives of Civil and Mechanical Engineering. 4(2). 41–47. 1 indexed citations
20.
Hahn, Ellen J., et al.. (2004). Effectiveness of a quit and win contest with a low-income population. Preventive Medicine. 39(3). 543–550. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026